Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Secukinumab 150mg/1ml inj pre-filled disposable devices
1001030AFAAAAAA
|
Secukinumab | Secukinumab | Musculoskeletal and Joint Diseases | 2 |
|
Cosentyx 150mg/1ml inj pre-filled syringes
1001030AFBBABAB
|
Cosentyx | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Cosentyx 150mg/1ml solution for injection pre-filled pens
1001030AFBBAAAA
|
Cosentyx | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Cosentyx 300mg/2ml solution for injection pre-filled pens
1001030AFBBACAC
|
Cosentyx | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Cosentyx 75mg/0.5ml inj pre-filled syringes
1001030AFBBADAD
|
Cosentyx | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Secukinumab 150mg/1ml inj pre-filled syringes
1001030AFAAABAB
|
Secukinumab | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Secukinumab 300mg/2ml inj pre-filled disposable devices
1001030AFAAACAC
|
Secukinumab | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
|
Secukinumab 75mg/0.5ml inj pre-filled syringes
1001030AFAAADAD
|
Secukinumab | Secukinumab | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.